403
Participants
Start Date
January 31, 2014
Primary Completion Date
May 30, 2022
Study Completion Date
June 21, 2023
Bendamustine
90 milligram per meter square (mg/m\^2) administered intravenously on Days 1 to 2 of Cycles 1 to 6.
Rituximab
375 mg/m\^2 administered intravenously on Day 1 of Cycles 1 to 6.
Cyclophosphamide
750 mg/m\^2 administered intravenously on Day 1 of Cycles 1 to 6.
Doxorubicin
50 mg/m\^2 administered intravenously on Day 1 of Cycles 1 to 6.
Vincristine
1.4 mg/m\^2 (maximum total 2 mg) administered intravenously on Day 1 of Cycles 1 to 6.
Prednisone
100 mg administered orally on Days 1 to 5 of Cycles 1 to 6.
PCI-32765 (Ibrutinib)
560 mg (4\*140 mg) capsules administered orally once daily, continuously starting on Cycle 1, Day 1.
Placebo
Placebo (4 capsules) matched to ibrutinib administered orally once daily, continuously starting on Cycle 1, Day 1.
Gilbert
Campbell
Duarte
La Jolla
Los Angeles
Orange
Ocala
Chicago
Maywood
Indianapolis
Westwood
Lexington
Lafayette
Scarborough
Baltimore
Bethesda
Boston
Ann Arbor
Battle Creek
Detroit
Saint Louis Park
Denville
New York
Hickory
Pinehurst
Bend
Pittsburgh
Sioux Falls
Houston
Lubbock
Spokane
Green Bay
Buenos Aires
Ciudad Autonoma Buenos Aires
Córdoba
La Capital
Mendoza
Santa Fe
Adelaide
Fitzroy
Heidelberg
South Brisbane
Wahroonga
Westmead
Anderlecht
Edegem
Ghent
Leuven
Namur
Wilrijk
Porto Alegre
Rio de Janeiro
Salvador
São Paulo
Beijing
Chengdu
Guangzhou
Hangzhou
Harbin
Nanjing
Shanghai
Tianjin
Nice
Paris
Pessac
Pierre-Bénite
Rennes
Berlin
Giessen
Göttingen
Ludwigshafen
Magdeburg
Mainz
München
Wiesbaden
Hadera
Haifa
Jerusalem
Nahariya
Netanya
Petah Tikva
Ramat Gan
Chūōku
Hiroshima
Isehara
Kobe
Nagoya
Osaka Sayama Shi
Sapporo
Sendai
Suita-shi
Tokyo
Gdynia
Olsztyn
Warsaw
Bayamón
Ponce
San Juan
Krasnodar
Moscow
Nizny Novgorod
Petrozavodsk
Pyatigorsk
Rostov-on-Don
Saint Petersburg
Syktyvkar
Volgograd
Jeollanam-do
Seoul
Barcelona
Madrid
Pozuelo de Alarcón
Salamanca
Gothenburg
Linköping
Luleå
Uppsala
Ankara
Antalya
Istanbul
Izmir
Kayseri
Cherkasy
Ivano-Frankivsk
Khmelnitskiy
Kiev
Lviv
Uzhhorod
Glasgow
London
Newcastle upon Tyne
Plymouth
Portsmouth
Sutton
Swansea
Collaborators (1)
Pharmacyclics LLC.
INDUSTRY
Janssen Research & Development, LLC
INDUSTRY